Company Filing History:
Years Active: 2021-2023
Title: Susan Nicole Pieniazek: Innovator in Pharmaceutical Compounds
Introduction
Susan Nicole Pieniazek is a notable inventor based in Robbinsville, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target integrins. With a total of 2 patents, her work is instrumental in advancing medical treatments.
Latest Patents
Pieniazek's latest patents include innovative compounds that are designed as αV integrin inhibitors. These compounds, which are categorized as cyclobutanes and azetidine-containing mono and spirocyclic compounds, serve as antagonists to αV-containing integrins. The inventions also encompass pharmaceutical compositions that utilize these compounds for treating various diseases and disorders, including pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders.
Career Highlights
Susan Pieniazek is currently employed at Bristol-Myers Squibb Company, where she continues to push the boundaries of pharmaceutical research. Her expertise in integrin inhibitors has positioned her as a key player in the development of new therapeutic strategies.
Collaborations
Throughout her career, Pieniazek has collaborated with talented colleagues, including Pratik Devasthale and Fang Moore. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Susan Nicole Pieniazek's contributions to pharmaceutical innovations highlight her role as a leading inventor in the field. Her work on integrin inhibitors is paving the way for new treatments that address critical health challenges.